The ROE as of November 2024 (TTM) for ChitogenX Inc. (CHNXF) is 27.19%

According to ChitogenX Inc.’s latest financial reports and current stock price. The company's current ROE is 27.19%. This represents a change of 291.46% compared to the average of 6.94% of the last 4 quarters.

ChitogenX Inc. (CHNXF) Historical ROE (quarterly & annually)

How has CHNXF ROE performed in the past?

The mean historical ROE of ChitogenX Inc. over the last ten years is -76.82%. The current 27.19% ROE has changed -135.39% with respect to the historical average. Over the past ten years (40 quarters), CHNXF's ROE was at its highest in in the January 2016 quarter at 1.79%. The ROE was at its lowest in in the January 2018 quarter at -687.24%.

ChitogenX Inc. (CHNXF) ROE by Quarter and Year

Discovering the peaks and valleys of ChitogenX Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ChitogenX Inc. (CHNXF) Average ROE

How has CHNXF ROE performed in the past?

The current ROE of ChitogenX Inc. (CHNXF) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

ChitogenX Inc. (CHNXF) ROE vs. Peers

How is CHNXF’s ROE compared to its peers?

ChitogenX Inc.’s ROE is greater than Advanced Proteome Therapeutics Corporation (0%), greater than Cellectis S.A. (-76.69%), greater than Biotron Limited (-504.53%), greater than Bioasis Technologies Inc. (0%), greater than Ceapro Inc. (-21.67%), less than Mymetics Corporation (11.39%), greater than ProtoKinetix, Incorporated (-91.48%), less than Statera Biopharma, Inc. (6.68%), less than IMV Inc. (0%), less than Forward Pharma A/S (0%), greater than Lipella Pharmaceuticals Inc. (0%), greater than Senti Biosciences, Inc. (-2.53%), greater than Fennec Pharmaceuticals Inc. (-107557.27%), greater than Monopar Therapeutics Inc. (-154.84%), less than Applied Molecular Transport Inc. (31.99%), greater than Scopus BioPharma Inc. (-21731.73%), greater than Magenta Therapeutics, Inc. (-131.59%), less than Marizyme, Inc. (911.69%), greater than Allena Pharmaceuticals, Inc. (-14.27%), less than null (448.62%), greater than null (-160.99%),

Build a custom stock screener for ChitogenX Inc. (CHNXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ChitogenX Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ChitogenX Inc. (CHNXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ChitogenX Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.